Lung disease associated with α1-antitrypsin deficiency

Proceedings of the American Thoracic Society

Volumn 7, Issue 6, 2010, Pages 381-386

  Tuder, Rubin M ^a   Janciauskiene, Sabina M ^b   Petrache, Irina ^c,d  

^a UNIVERSITY OF COLORADO   (United States)

^b LEIBNIZ UNIVERSITY HANNOVER   (Germany)

^c Pulmonary and Critical Care Medicine   (United States)

^d INDIANA UNIVERSITY   (United States)

Author keywords

Apoptosis; COPD; Inflammation; Proteinase inhibitor; Serpin

Indexed keywords

CASPASE 3;

ALPHA 1 ANTITRYPSIN DEFICIENCY; APOPTOSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; EMPHYSEMA; HUMAN; METABOLISM; PATHOPHYSIOLOGY; REVIEW;

ALPHA 1-ANTITRYPSIN DEFICIENCY; APOPTOSIS; CASPASE 3; EMPHYSEMA; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 79952663591     PISSN: 15463222     EISSN: 19435665     Source Type: Journal    
DOI: 10.1513/pats.201002-020AW     Document Type: Conference Paper

References (81)

1. Lomas DA. The selective advantage of a1-antitrypsin deficiency. Am J Respir Crit Care Med 2006;173:1072-1077.
2. Stoller JK, Aboussouan LS. a1-Antitrypsin deficiency. Lancet 2005;2005: 2225-2236.
3. Tuder RM, Petrache I. Molecular multitasking in the airspace: a1-antitrypsin takes on thrombin and plasmin. Am J Respir Cell Mol Biol 2007;37:130-134.
4. Janciauskiene S. Conformational properties of serine proteinase inhibitors (serpins) confer multiple pathophysiological roles. Biochim Biophys Acta 2001;1535:221-235.
5. Eriksson S. Studies in a1-atitrypsin. Acta Med Scand 1965;177:1-85.
6. Shapiro SD. The pathogenesis of emphysema: the elastase:antielastase hypothesis 30 years later. Proc Assoc Am Physicians 1995;107:346-352.
7. Tuder RM, Yoshida T, Arap W, Pasqualini R, Petrache I. Cellular and molecular mechanisms of alveolar destruction in emphysema: an evolutionary perspective. Proc Am Thorac Soc 2006;3:503-510.
8. Tuder RM, Yoshida T, Fijalkowka I, Biswal S, Petrache I. Role of lung maintenance program in the heterogeneity of lung destruction in emphysema. Proc Am Thorac Soc 2006;3:673-679.
9. Tuder RM, Voelkel NF. Pathobiology of chronic bronchitis and emphysema. In N.F. Voelkel and W. McNee, editors. Chronic obstructive lung disease, 1st ed. 2001; Montreal, Quebec, Canada: B.C. Decker.
10. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, Le Cras TD, Abman SH, Hirth P, Waltenberger J, Voelkel NF. Inhibition of vascular endothelial growth factor receptors causes lung cell apoptosis and emphysema. J Clin Invest 2000;106:1311-1319.
11. Tang K, Rossiter HB, Wagner PD, Breen EC. Lung-targeted VEGF inactivation leads to an emphysema phenotype in mice. J Appl Physiol 2004;97:1559-1566.
12. Voelkel NF, Vandivier RW, Tuder RM. Vascular endothelial growth factor in the lung. Am J Physiol Lung Cell Mol Physiol 2006;290: L209-L221.
13. Tuder RM, McGrath S, Neptune E. The pathobiological mechanisms of emphysema models: what do they have in common? Pulm Pharmacol Ther 2003;16:67-78.
14. Le A, Zielinski R, He C, Crow MT, Biswal S, Tuder RM, Becker PM. Pulmonary epithelial neuropilin-1 deletion enhances development of cigarette smoke-induced emphysema. Am J Respir Crit Care Med 2009;180:396-406.
15. Tuder RM, Petrache I, Elias JA, Voelkel NF, Henson PM. Apoptosis and emphysema: the missing link. Am J Respir Cell Mol Biol 2003;28: 551-554.
16. Aoshiba K, Nagai A. Apoptosis in chronic obstructive pulmonary disease. Nippon Rinsho 1999;57:1972-1975.
17. Segura-Valdez L, Pardo A, Gaxiola M, Uhal BD, Becerril C, Selman M. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest 2000;117:684-694.
18. Kasahara Y, Tuder RM, Cool CD, Lynch DA, Flores SC, Voelkel NF. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med 2001;163:737-744.
19. Zheng T, Kang MJ, Crothers K, Zhu Z, Liu W, Lee CG, Rabach LA, Chapman HA, Homer RJ, Aldous D, et al. Role of cathepsin Sdependent epithelial cell apoptosis in IFN-g-induced alveolar remodeling and pulmonary emphysema. J Immunol 2005;174:8106-8115.
20. Tuder RM, Zhen L, Cho CY, Taraseviciene-Stewart L, Kasahara Y, Salvemini D, Voelkel NF, Flores SC. Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am J Respir Cell Mol Biol 2003;29:88-97.
21. Rangasamy T, Cho CY, Thimmulappa RK, Zhen L, Srisuma SS, Kensler TW, Yamamoto M, Petrache I, Tuder RM, Biswal S. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J Clin Invest 2004;114:1248-1259.
22. Sussan TE, Rangasamy T, Blake DJ, Malhotra D, El-Haddad H, Bedja D, Yates MS, Kombairaju P, Yamamoto M, Liby KT, et al. Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice. Proc Natl Acad Sci USA 2009;106:250-255.
23. Tuder RM. Aging and cigarette smoke: fueling the fire. Am J Respir Crit Care Med 2006;174:490-491.
24. MacNee W, Tuder RM. New paradigms in the pathogenesis of chronic obstructive pulmonary disease I. Proc Am Thorac Soc 2009;6:527-531.
25. Aoshiba K, Nagai A. Senescence hypothesis for the pathogenetic mechanism of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2009;6:596-601.
26. Tsuji T, Aoshiba K, Nagai A. Cigarette smoke induces senescence in alveolar epithelial cells. Am J Resp Cell Mol Biol 2004;31:643-649.
27. Nyunoya T, Monick MM, Klingelhutz A, Yarovinsky TO, Cagley JR, Hunninghake GW. Cigarette smoke induces cellular senescence. Am J Respir Cell Mol Biol 2006;35:681-688.
28. Tsuji T, Aoshiba K, Nagai A. Alveolar cell senescence in pulmonary emphysema patients. Am J Respir Crit Care Med 2006;174:886-893.
29. Morla M, Busquets X, Pons J, Sauleda J, MacNee W, Agusti AG. Telomere shortening in smokers with and without COPD. Eur Respir J 2006;27:525-528.
30. Savale L, Chaouat A, Bastuji-Garin S, Marcos E, Boyer L, Maitre B, Sarni M, Housset B, Weitzenblum E, Matrat M, et al. Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009;179:566-571.
31. Rahman I, van Schadewijk AAM, Crowther AJL, Hiemstra PS, Stolk J, MacNee W, De Boer WI. 4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;166:490-495.
32. Deslee G, Woods JC, Moore C, Conradi SH, Gierada DS, Atkinson JJ, Battaile JT, Liu L, Patterson GA, Adair-Kirk TL, et al. Oxidative damage to nucleic acids in severe emphysema. Chest 2009;135:965-974.
33. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005;120:513-522.
34. Liu H, Fergusson MM, Castilho RM, Liu J, Cao L, Chen J, Malide D, Rovira II, Schimel D, Kuo CJ, et al. Augmented Wnt signaling in a mammalian model of accelerated aging. Science 2007;317:803-806.
35. Agusti A, MacNee W, Donaldson K, Cosio M. Hypothesis: does COPD have an autoimmune component? Thorax 2003;58:832-834.
36. Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 2009;360:2445-2454.
37. Hogg JC. Why does airway inflammation persist after the smoking stops? Thorax 2006;61:96-97.
38. Houghton AM, Quintero PA, Perkins DL, Kobayashi DK, Kelley DG, Marconcini LA, Mecham RP, Senior RM, Shapiro SD. Elastin fragments drive disease progression in a murine model of emphysema. J Clin Invest 2006;116:753-759.
39. Weathington NM, van Houwelingen AH, Noerager BD, Jackson PL, Kraneveld AD, Galin FS, Folkerts G, Nijkamp FP, Blalock JE. A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nat Med 2006;12:317-323.
40. Lee SH, Goswami S, Grudo A, Song LZ, Bandi V, Goodnight-White S, Green L, Hacken-Bitar J, Huh J, Bakaeen F, et al. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med 2007;13:567-569.
41. Petrache I, Natarajan V, Zhen L, Medler TR, Richter AT, Cho C, Hubbard WC, Berdyshev EV, Tuder RM. Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat Med 2005;11:491-498.
42. Medler, T. R., D. N. Petrusca, P. J. Lee, W. C. Hubbard, E. V. Berdyshev, J. Skirball, K. Kamocki, E. Schuchman, R. M. Tuder, and I. Petrache. Apoptotic sphingolipid signaling by ceramides in lung endothelial cells. Am J Respir Cell Mol Biol 38:639-646.
43. Kang MJ, Lee CG, Lee JY, Dela Cruz CS, Chen ZJ, Enelow R, Elias JA. Cigarette smoke selectively enhances viral PAMP and virusesinduced pulmonary innate immunity and remodeling responses. J Clin Invest 2008;118:2771-2784.
44. Shapiro L, Pott GB, Ralston AH. a1-Antitrypsin inhibits human immunodeficiency virus type 1. FASEB J 2001;15:115-122.
45. Terai C, Kornbluth RS, Pauza CD, Richman DD, Carson DA. Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J Clin Invest 1991;87:1710-1715.
46. Ikari Y, Mulvihill E, Schwartz SM. a1-Proteinase inhibitor, a1-antichymotrypsin, and a2-macroglolbulin are the antiapoptotic factors of vascular smooth muscle cells. J Biol Chem 2001;276: 11798-11803.
47. Daemen, M. A., V. H. Heemskerk, van't Veer C, Denecker G, Wolfs TG, Vandenabeele P, Buurman WA. Functional protection by acute phase proteins a1-acid glycoprotein and a1-antitrypsin against ischemia/ reperfusion injury by preventing apoptosis and inflammation. Circulation 2000;102:1420-1426.
48. Petrache I, Fijalkowska I, Zhen L, Medler TR, Brown E, Cruz P, Choe KH, Taraseviciene-Stewart L, Scerbavicius R, Shapiro L, et al.Anovel antiapoptotic role for a1-antitrypsin in the prevention of pulmonary emphysema. Am J Respir Crit Care Med 2006;173:1222-1228.
49. Petrache I, Fijalkowska I, Medler TR, Skirball J, Cruz P, Zhen L, Petrache HI, Flotte T, Tuder RM. Alpha-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis. Am J Pathol 2006;169:1155-1166.
50. Sohrab S, Petrusca DN, Lockett AD, Schweitzer KS, Rush NI, Gu Y, Kamocki K, Garrison J, Petrache I. Mechanism of a1-antitrypsin endocytosis by lung endothelium. FASEB J 2009;23:3149-3158.
51. Lin SY, Makino K, Xia W, Matin A, Wen Y, Kwong KY, Bourguignon L, Hung MC. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol 2001;3:802-808.
52. Liao HJ, Carpenter G. Role of the Sec61 translocon in EGF receptor trafficking to the nucleus and gene expression. Mol Biol Cell 2007;18: 1064-1072.
53. Song S, Goudy K, Campbell-Thompson M, Wasserfall C, Scott-Jorgensen M, Wang J, Tang Q, Crawford JM, Ellis TM, Atkinson MA, et al. Recombinant adeno-associated virus-mediated a1-antitrypsin gene therapy prevents type I diabetes in NOD mice. Gene Ther 2004;11: 181-186.
54. Henson PM, Cosgrove GP, Vandivier RW. State of the art: apoptosis and cell homeostasis in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006;3:512-516.
55. Wencker M, Banik N, Buhl R, Seidel R, Konietzko N. Long-term treatment of a1-antitrypsin deficiency-related pulmonary emphysema with human alpha1-antitrypsin. Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL)-a1-AT-study group. Eur Respir J 1998;11:428-433.
56. Breit SN, Robinson JP, Luckhurst E, Clark P, Penny R. Immunoregulation by a1-antitrypsin. J Clin Lab Immunol 1982;7:127-131.
57. Khan AJ, Evans HE, Agbayani MM. Defective neutrophil chemotaxis in patients with a1-antitrypsin deficiency. Eur J Pediatr 1986;144: 464-466.
58. Churg A, Wang RD, Xie C, Wright JL. a1-Antitrypsin ameliorates cigarette smoke-induced emphysema in the mouse. Am J Respir Crit Care Med 2003;168:199-207.
59. Griese M, Latzin P, Kappler M, Weckerle K, Heinzlmaier T, Bernhardt T, Hartl D. a1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients. Eur Respir J 2007;29:240-250.
60. Sandstrom CS, Pitulainen E, Janciauskiene S. Augmentation therapy in emphysema patient with ZZ a1-antitrypsin deficiency. Respir Med CME 2008;1:153-157.
61. Breit SN, Robinson JP, Penny R. The effect of a1-antitrypsin on phagocyte function. J Clin Lab Immunol 1983;10:147-149.
62. Mulgrew AT, Taggart CC, Lawless MW, Greene CM, Brantly ML, O'Neill SJ, McElvaney NG. Z a1-antitrypsin polymerizes in the lung and acts as a neutrophil chemoattractant. Chest 2004;125:1952-1957.
63. Hartl D, Latzin P, Hordijk P, Marcos V, Rudolph C, Woischnik M, Krauss-Etschmann S, Koller B, Reinhardt D, Roscher AA, et al. Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease. Nat Med 2007;13:1423-1430.
64. Pease JE, Sabroe I. The role of interleukin-8 and its receptors in inflammatory lung disease: implications for therapy. Am J Respir Med 2002;1:19-25.
65. Dabbagh K, Laurent GJ, Shock A, Leoni P, Papakrivopoulou J, Chambers RC. a1-Antitrypsin stimulates fibroblast proliferation and procollagen production and activates classical MAP kinase signalling pathways. J Cell Physiol 2001;186:73-81.
66. Janciauskiene S, Zelvyte I, Jansson L, Stevens T. Divergent effects of a1-antitrypsin on neutrophil activation, in vitro. Biochem Biophys Res Commun 2004;315:288-296.
67. Janciauskiene SM, Nita IM, Stevens T. a1-Antitrypsin, old dog, new tricks: a1-antitrypsin exerts in vitro anti-inflammatory activity in human monocytes by elevating cAMP. J Biol Chem 2007;282:8573-8582.
68. Subramaniyam D, Virtala R, Pawlowski K, Clausen IG, Warkentin S, Stevens T, Janciauskiene S. TNF-a-induced self expression in human lung endothelial cells is inhibited by native and oxidized a1-antitrypsin. Int J Biochem Cell Biol 2008;40:258-271.
69. Libert C, Van MW, Brouckaert P, Fiers W. a1-Antitrypsin inhibits the lethal response to TNF in mice. J Immunol 1996;157:5126-5129.
70. Churg A, Dai J, Zay K, Karsan A, Hendricks R, Yee C, Martin R, MacKenzie R, Xie C, Zhang L, et al. a1-Antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute anti-inflammatory effects. Lab Invest 2001;81:1119-1131.
71. Cantin AM, Hanrahan JW, Bilodeau G, Ellis L, Dupuis A, Liao J, Zielenski J, Durie P. Cystic fibrosis transmembrane conductance regulator function is suppressed in cigarette smokers. Am J Respir Crit Care Med 2006;173:1139-1144.
72. Lewis EC, Shapiro L, Bowers OJ, Dinarello CA. a1-Antitrypsin monotherapy prolongs islet allograft survival in mice. Proc Natl Acad Sci USA 2005;102:12153-12158.
73. Tilg H, Vannier E, Vachino G, Dinarello CA, Mier JW. Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells. J ExpMed 1993;178:1629-1636.
74. Arend WP, Malyak M, Guthridge CJ, Gabay C. Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol 1998;16:27-55.
75. Hubbard RC, Fells G, Gadek J, Pacholok S, Humes J, Crystal RG. Neutrophil accumulation in the lung in a1-antitrypsin deficiency: spontaneous release of leukotriene B4 by alveolar macrophages. J Clin Invest 1991;88:891-897.
76. Hill AT, Campbell EJ, Bayley DL, Hill SL, Stockley RA. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with a1-antitrypsin deficiency (PiZ). Am J Respir Crit Care Med 1999;160:1968-1975.
77. Lieberman J. Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting data. Chest 2000;118:1480-1485.
78. Lazrak A, Nita I, Subramaniyam D, Wei S, Song W, Ji HL, Janciauskiene S, Matalon S. a1-Antitrypsin inhibits epithelial Na1 transport in vitro and in vivo. Am J Respir Cell Mol Biol 2009;41:261-270.
79. Churg A, Wang X, Wang RD, Meixner SC, Pryzdial ELG, Wright JL. a1-Antitrypsin suppresses TNF-a andMMP-12 production by cigarette smokestimulated macrophages. Am J Respir Cell Mol Biol 2007;37:144-151.
80. Mahadeva R, Atkinson C, Li Z, Stewart S, Janciauskiene S, Kelley DG, Parmar J, Pitman R, Shapiro SD, Lomas DA. Polymers of Z a1-antitrypsin co-localize with neutrophils in emphysematous alveoli and are chemotactic in vivo. Am J Pathol 2005;166:377-386.
81. Greene CM, Miller SD, Carroll TP, Oglesby IK, Ahmed F, O'Mahony M, Taggart CC, McElvaney NG, O'Neill SJ. Anti-apoptotic effects of Z a1-antitrypsin in human bronchial epithelial cells. Eur Respir J 2010;35:1155-1163.